Results 141 to 150 of about 4,403,877 (318)

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec   +6 more
wiley   +1 more source

Solution-Focused Collective Action: A Response to Harry Korman, Peter De Jong, and Sara Smock Jordan

open access: yes, 2022
L\u27édition de juillet 2021 de cette revue contenait à la fois une réponse (Shennan, 2021) à l\u27article Steve de Shazer\u27s Theory Development (Korman et al., 2020), et une réponse à cette réponse par les auteurs de l\u27article initial (Korman et al.
Collective, Solution-Focused
core  

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio   +8 more
wiley   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Existence, Uniqueness and Stability of Mild Solution of Lipschitzian Quantum Stochastic Differential Equations

open access: yes, 2014
We introduce the concept of a mild solution of Lipschitzian quantum stochastic differential equations (QSDEs). Results on existence,uniqueness and stability of mild solution of QSDEs are established.
Agarana, M. C.   +4 more
core  

Unveiling the complexities of mild stroke: an interpretative phenomenological analysis of the mild stroke experience

open access: yes, 2019
Introduction: Limited research has been conducted from a longitudinal and qualitative perspective on the experience of life after mild stroke. This restricts the knowledge held in this area.
Gustafsson, Louise   +5 more
core   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao   +5 more
wiley   +1 more source

Impulsive fractional differential inclusions with infinite delay

open access: yesElectronic Journal of Differential Equations, 2013
In this article, we apply Bohnenblust-Karlin's fixed point theorem to prove the existence of mild solutions for a class of impulsive fractional equations inclusions with infinite delay. An example is given to illustrate the theory.
Khalida Aissani, Mouffak Benchohra
doaj  

Artificial Intelligence as A Solution for Mild Illnesses

open access: yes
The integration of Artificial Intelligence (AI) into healthcare has significantly revolutionized patient care, offering novel solutions for both complex and mild medical conditions. While mild illnesses—such as common colds, minor allergies, and early-stage infections—are generally non-threatening, they often disrupt daily life and strain healthcare ...
openaire   +1 more source

Home - About - Disclaimer - Privacy